Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04074486 · ClinicalTrials.gov registry record
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
A clinical trial, sponsored by BrainScope Company.
- Completed
- Registry status
- 1,318
- Enrollment target
NCT04074486: Completed study, sponsored by BrainScope Company.
NCT04074486 is a clinical trial that has completed, run by BrainScope Company. The registered enrollment target is 1,318 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04074486 has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 1,318 participants
- Enrollment target
Study Summary
This study is designed to collect data which will be used to associate changes in EEG, neurocognitive performance, eNPC and clinical symptoms in concussion subtypes. The study will recruit males and females, 13-50 years old, from Concussion Centers/Programs, Sports Venues and Emergency Departments (ED) across the country, over an 18-month period (Phase 2, 12 months for Algorithm Development and Norming, and Phase 3, 6 months for Validation).
Primary Outcome
Sensitivity and specificity of the expanded CI for assessment of the likelihood of concussion in subjects ages 13-50 who sustained a closed head injury.
Interventions
- DEVICE BrainScope Ahead 300iP-O
- DIAGNOSTIC_TEST SCAT5
- DIAGNOSTIC_TEST Near Point Convergence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,318 participants |
| Start Date | 2019-10-02 |
| Est. Completion | 2022-03-31 |
What the finished NCT04074486 record still lists
NCT04074486 is an observational study that tracks outcomes without assigning an intervention. Its 1,318 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which BrainScope Ahead 300iP-O is the first listed.
NCT04074486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04074486 about?
NCT04074486 is a clinical study titled "Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC". This study is designed to collect data which will be used to associate changes in EEG, neurocognitive performance, eNPC and clinical symptoms in concussion subtypes. The study will recruit males and females, 13-50 years old, from Concussion Centers/Programs, Sports Venues and Emergency Departments (...
What is the current status of trial NCT04074486?
This trial is currently completed. The enrollment target is 1,318 participants. The study started on 2019-10-02. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04074486?
The interventions under investigation include: BrainScope Ahead 300iP-O (DEVICE), SCAT5 (DIAGNOSTIC_TEST), Near Point Convergence (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04074486?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT05762302 · 1,316 participants · NA
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI